Literature DB >> 1312780

Sarcolemmal Na(+)-K(+)-ATPase activity in congestive heart failure due to myocardial infarction.

I M Dixon1, T Hata, N S Dhalla.   

Abstract

Because the Na+ pump is considered to modulate the contractile force development by the cardiac muscle and depressed cardiac pump function is the hallmark of congestive heart failure, we characterized the sarcolemmal Na(+)-K(+)-ATPase activity in failing rat hearts after myocardial infarction. For this purpose, the left ventricular coronary artery was ligated, and hearts were examined 4, 8, and 16 wk later; sham-operated animals served as controls. Hemodynamic assessment revealed the presence of abnormal cardiac function at 4, 8, and 16 wk. Although accumulation of ascites in the abdominal cavity was present in experimental animals at 4 wk, other clinical signs of congestive heart failure in experimental rats including lung congestion and cardiac dilatation were evident 8 and 16 wk after induction of myocardial infarction. The depression in Na(+)-K(+)-ATPase activity in purified sarcolemmal membrane from the uninfarcted experimental left ventricle at 8 wk was associated with depressed Vmax without any changes in the affinities for Mg-ATP, Na+, and K+ or the pH optimum for the enzyme. The Kd values of both the high- and low-affinity binding sites for [3H]ouabain, which is believed to interact with Na(+)-K(+)-ATPase, were increased; however, no change in the density of either class of ouabain binding site was evident. The depression of Na(+)-K(+)-ATPase activity in failing hearts at 16 wk of myocardial infarction was not different from that observed at 8 wk but the enzyme activity was not altered at 4 wk of coronary occlusion. These data support the view that depression of Na(+)-K(+)-ATPase activity may serve as an adaptive mechanism during the development of congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312780     DOI: 10.1152/ajpcell.1992.262.3.C664

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  Myocardial region (right or left ventricle) and aetiology of heart failure can influence the inotropic effect of ouabain in failing human myocardium.

Authors:  R Padrini; M Panfili; G Magnolfi; D Piovan; D Casarotto; M Ferrari
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

2.  ACE inhibition prevents diastolic Ca2+ overload and loss of myofilament Ca2+ sensitivity after myocardial infarction.

Authors:  S Zalvidea; L André; X Loyer; C Cassan; Y Sainte-Marie; J Thireau; I Sjaastad; C Heymes; J-L Pasquié; O Cazorla; F Aimond; S Richard
Journal:  Curr Mol Med       Date:  2012-02       Impact factor: 2.222

Review 3.  Role of various proteases in cardiac remodeling and progression of heart failure.

Authors:  Alison L Müller; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

4.  Constitutive overexpression of phosphomimetic phospholemman S68E mutant results in arrhythmias, early mortality, and heart failure: potential involvement of Na+/Ca2+ exchanger.

Authors:  Jianliang Song; Erhe Gao; Jufang Wang; Xue-Qian Zhang; Tung O Chan; Walter J Koch; Xiying Shang; Jeffrey I Joseph; Blaise Z Peterson; Arthur M Feldman; Joseph Y Cheung
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-11       Impact factor: 4.733

5.  Phospholemman overexpression inhibits Na+-K+-ATPase in adult rat cardiac myocytes: relevance to decreased Na+ pump activity in postinfarction myocytes.

Authors:  Xue-Qian Zhang; J Randall Moorman; Belinda A Ahlers; Lois L Carl; Douglas E Lake; Jianliang Song; J Paul Mounsey; Amy L Tucker; Yiu-Mo Chan; Lawrence I Rothblum; Richard C Stahl; David J Carey; Joseph Y Cheung
Journal:  J Appl Physiol (1985)       Date:  2005-09-29

6.  Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction.

Authors:  I M Dixon; H Ju; D S Jassal; D J Peterson
Journal:  Mol Cell Biochem       Date:  1996-12-06       Impact factor: 3.396

Review 7.  Phospholemman: a novel cardiac stress protein.

Authors:  Joseph Y Cheung; Xue-Qian Zhang; Jianliang Song; Erhe Gao; Joseph E Rabinowitz; Tung O Chan; Jufang Wang
Journal:  Clin Transl Sci       Date:  2010-08       Impact factor: 4.689

8.  The second member of transient receptor potential-melastatin channel family protects hearts from ischemia-reperfusion injury.

Authors:  Barbara A Miller; JuFang Wang; Iwona Hirschler-Laszkiewicz; Erhe Gao; Jianliang Song; Xue-Qian Zhang; Walter J Koch; Muniswamy Madesh; Karthik Mallilankaraman; Tongda Gu; Shu-jen Chen; Kerry Keefer; Kathleen Conrad; Arthur M Feldman; Joseph Y Cheung
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-01       Impact factor: 4.733

9.  Characterization of adenylyl cyclase in heart sarcolemma in the absence or presence of alamethicin.

Authors:  R Sethi; K S Dhalla; K R Shah; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

10.  Reduced 3H-ouabain binding site (Na,K-ATPase) concentration in ventricular myocardium of dogs with tachycardia induced heart failure.

Authors:  T A Schmidt; J S Larsen; R P Shannon; K Komamura; D E Vatner; K Kjeldsen
Journal:  Basic Res Cardiol       Date:  1993 Nov-Dec       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.